FibroBiologics, Inc. Common Stock (FBLG) is a publicly traded Healthcare sector company. As of August 24, 2026, FBLG trades at $1.40 with a market cap of $9.59M and a P/E ratio of -3.39. FBLG moved -2.08% today. Year to date, FBLG is -67.99%; over the trailing twelve months it is -87.77%. Its 52-week range spans $0.62 to $47.72. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces FBLG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for FBLG, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.40 |
| Market Cap | $9.59M |
| P/E Ratio | -3.39 |
| EPS | $-0.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $47.72 |
| 52-Week Low | $0.62 |
| Volume | 87.31K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-18.65M |
| Gross Margin | 0.00% |
1 analysts cover FBLG: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.